DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $72.76 million. The enterprise value is $91.22 million.
| Market Cap | 72.76M |
| Enterprise Value | 91.22M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 9.79 million shares outstanding. The number of shares has increased by 171.67% in one year.
| Current Share Class | 9.79M |
| Shares Outstanding | 9.79M |
| Shares Change (YoY) | +171.67% |
| Shares Change (QoQ) | +41.95% |
| Owned by Insiders (%) | 15.27% |
| Owned by Institutions (%) | 3.79% |
| Float | 7.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.49 |
| Forward PS | 3.04 |
| PB Ratio | 1.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.59.
| Current Ratio | 2.31 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.01 |
Financial Efficiency
Return on equity (ROE) is -59.91% and return on invested capital (ROIC) is -21.73%.
| Return on Equity (ROE) | -59.91% |
| Return on Assets (ROA) | -19.42% |
| Return on Invested Capital (ROIC) | -21.73% |
| Return on Capital Employed (ROCE) | -36.59% |
| Weighted Average Cost of Capital (WACC) | 11.17% |
| Revenue Per Employee | $127,261 |
| Profits Per Employee | -$247,932 |
| Employee Count | 165 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.94 |
Taxes
In the past 12 months, DarioHealth has paid $467,000 in taxes.
| Income Tax | 467,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.33% in the last 52 weeks. The beta is 1.12, so DarioHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -12.33% |
| 50-Day Moving Average | 7.13 |
| 200-Day Moving Average | 9.48 |
| Relative Strength Index (RSI) | 53.14 |
| Average Volume (20 Days) | 29,708 |
Short Selling Information
The latest short interest is 85,772, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 85,772 |
| Short Previous Month | 75,831 |
| Short % of Shares Out | 0.88% |
| Short % of Float | 1.12% |
| Short Ratio (days to cover) | 5.34 |
Income Statement
In the last 12 months, DarioHealth had revenue of $21.00 million and -$40.91 million in losses. Loss per share was -$5.54.
| Revenue | 21.00M |
| Gross Profit | 12.93M |
| Operating Income | -31.83M |
| Pretax Income | -35.20M |
| Net Income | -40.91M |
| EBITDA | -29.72M |
| EBIT | -31.83M |
| Loss Per Share | -$5.54 |
Balance Sheet
The company has $13.96 million in cash and $32.41 million in debt, with a net cash position of -$18.45 million or -$1.88 per share.
| Cash & Cash Equivalents | 13.96M |
| Total Debt | 32.41M |
| Net Cash | -18.45M |
| Net Cash Per Share | -$1.88 |
| Equity (Book Value) | 55.09M |
| Book Value Per Share | 7.50 |
| Working Capital | 12.55M |
Cash Flow
In the last 12 months, operating cash flow was -$25.35 million and capital expenditures -$136,000, giving a free cash flow of -$25.48 million.
| Operating Cash Flow | -25.35M |
| Capital Expenditures | -136,000 |
| Depreciation & Amortization | 2.12M |
| Net Borrowing | n/a |
| Free Cash Flow | -25.48M |
| FCF Per Share | -$2.60 |
Margins
Gross margin is 61.57%, with operating and profit margins of -151.60% and -169.87%.
| Gross Margin | 61.57% |
| Operating Margin | -151.60% |
| Pretax Margin | -167.65% |
| Profit Margin | -169.87% |
| EBITDA Margin | -141.51% |
| EBIT Margin | -151.60% |
| FCF Margin | n/a |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -171.67% |
| Shareholder Yield | -171.67% |
| Earnings Yield | -55.84% |
| FCF Yield | -34.78% |
Analyst Forecast
The average price target for DarioHealth is $14.50, which is 95.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.50 |
| Price Target Difference | 95.16% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 26.15% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |